144 related articles for article (PubMed ID: 24151835)
1. Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas.
Phan V; Walters J; Brownlow B; Elbayoumi T
J Drug Target; 2013 Dec; 21(10):1001-11. PubMed ID: 24151835
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
3. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.
Gossner G; Choi M; Tan L; Fogoros S; Griffith KA; Kuenker M; Liu JR
Gynecol Oncol; 2007 Apr; 105(1):23-30. PubMed ID: 17234261
[TBL] [Abstract][Full Text] [Related]
4. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
Li Y; Mi C
Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
[TBL] [Abstract][Full Text] [Related]
5. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
Ping SY; Hour TC; Lin SR; Yu DS
Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
[TBL] [Abstract][Full Text] [Related]
6. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells.
Choi EJ; Kim T; Lee MS
Life Sci; 2007 Mar; 80(15):1403-8. PubMed ID: 17291540
[TBL] [Abstract][Full Text] [Related]
7. Physico-chemical characterization of asolectin-genistein liposomal system: An approach to analyze its in vitro antioxidant potential and effect in glioma cells viability.
Lopes de Azambuja CR; dos Santos LG; Rodrigues MR; Rodrigues RF; da Silveira EF; Azambuja JH; Flores AF; Horn AP; Dora CL; Muccillo-Baisch AL; Braganhol E; da Silva Pinto L; Parize AL; de Lima VR
Chem Phys Lipids; 2015 Dec; 193():24-35. PubMed ID: 26453973
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells.
Jeune MA; Kumi-Diaka J; Brown J
J Med Food; 2005; 8(4):469-75. PubMed ID: 16379557
[TBL] [Abstract][Full Text] [Related]
9. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
[TBL] [Abstract][Full Text] [Related]
10. Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status.
Thasni KA; Rojini G; Rakesh SN; Ratheeshkumar T; Babu MS; Srinivas G; Banerji A; Srinivas P
Eur J Pharmacol; 2008 Jul; 588(2-3):158-64. PubMed ID: 18514188
[TBL] [Abstract][Full Text] [Related]
11. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.
Davis JN; Singh B; Bhuiyan M; Sarkar FH
Nutr Cancer; 1998; 32(3):123-31. PubMed ID: 10050261
[TBL] [Abstract][Full Text] [Related]
12. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
[TBL] [Abstract][Full Text] [Related]
13. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
14. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
15. Genistein induces apoptosis in T lymphoma cells via mitochondrial damage.
Baxa DM; Luo X; Yoshimura FK
Nutr Cancer; 2005; 51(1):93-101. PubMed ID: 15749635
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth.
Gercel-Taylor C; Feitelson AK; Taylor DD
Anticancer Res; 2004; 24(2B):795-800. PubMed ID: 15161029
[TBL] [Abstract][Full Text] [Related]
17. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.
Uckun FM; Narla RK; Zeren T; Yanishevski Y; Myers DE; Waurzyniak B; Ek O; Schneider E; Messinger Y; Chelstrom LM; Gunther R; Evans W
Clin Cancer Res; 1998 May; 4(5):1125-34. PubMed ID: 9607569
[TBL] [Abstract][Full Text] [Related]
18. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
19. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
